脳の血管疾患とレウィ体の連続体におけるコレリン白質経路の地域的関連
Anna Rennie1, Milan Nemy1,2, Cene Jerele1,3
1Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden.
NPJ Parkinson's disease
|August 21, 2025
まとめ
選択的脆弱性を示唆するコレリン経路の白質異常が増加している. この脳血管疾患は 注意力や記憶といった 認知機能に影響します
科学分野:
- 神経科学
- 神経学
- 脳血管疾患の研究
背景:
- 脳血管疾患は,レウイ体 (LB) 連続体の障害で,レウイ体 (DLB) とプロドロマール-DLBの認知症を含む.
- LB連続体の患者は,対照群と比較して,全身およびコレリン白質内の白質シグナル異常 (WMSA) 量が高くなります.
- 選択的脆弱性か,または全局的なWMSAの結果か, WMSAの増加の原因は不明である.
研究 の 目的:
- LB連続体の患者におけるWMSAの上昇は選択的脆弱性によるものなのか,または全局的なWMSAによるものなのかを調査する.
- コリン性WMSA,神経変性,白質経路の整合性,および認知能力との関連を分析する.
主な方法:
- 帯状膜と外部のカプセル ホリナージック白質経路をモデル化するためにMRIを用いた.
- 分割されたWMSAの重なり合っている経路と脳葉によって.
- LB連続体の患者 (n=33) と対照群 (n=36) の間でのWMSA容量とコレリン白質の比率の比較
主要な成果:
- LB連続体の患者は,全局的なWMSAとは無関係に,ホリナージック白質のWMSAの体積と割合が著しく高かった.
- 塩素性WMSAは基礎前頭部神経変性と帯状回路と外側カプセル経路の整合性の低下と相関しています.
- コリン性WMSAの増加は,注意力や記憶力の低下と関連していました.
結論:
- Lewy体連続障害の患者におけるコレニルゲン経路の選択的脆弱性を示唆している.
- この選択的脆弱性は,DLBとプロドロマル-DLBにおける観察された脳血管疾患の負担と認知欠陥に寄与する可能性があります.
さらに関連する動画
関連する概念動画
Neural Regulation
39.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.9K
Cerebellum: Anatomical Regions
2.3K
The cerebellum, also known as the "little brain," is located in the posterior cranial fossa, inferior to the tentorium cerebelli and dorsal to the brainstem. It plays a significant role in motor control, coordination, and proprioception.
Cerebellar Structure
Externally, the cerebellum features a highly convoluted surface with numerous folia (narrow ridges) separated by shallow sulci (grooves). The cerebellum is divided into two hemispheres by a thin median structure known as the vermis. The...
Cerebellar Structure
Externally, the cerebellum features a highly convoluted surface with numerous folia (narrow ridges) separated by shallow sulci (grooves). The cerebellum is divided into two hemispheres by a thin median structure known as the vermis. The...
2.3K
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165


